Schühlen, Helmut <br/><br/>
[Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].  [electronic resource] 

 -  Herz  Aug 2007 
 - 419-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0340-9937 
<br/><br/><label>Standard No.: </label>10.1007/s00059-007-2999-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antihypertensive Agents--administration & dosage<br/>Death, Sudden, Cardiac--epidemiology<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Germany--epidemiology<br/>Humans<br/>Hydrochlorothiazide--administration & dosage<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Risk Assessment--methods<br/>Risk Factors<br/>Tetrazoles--administration & dosage<br/>Treatment Outcome<br/>Valine--administration & dosage<br/>Valsartan